Holmdel, NJ, United States of America

David M Tschaen

This inventor holds 31 USPTO granted patents and 2 EPO patents, primarily in Asymmetric Synthesis. Top assignees: Merck + Co., Inc., Banyu Pharmaceutical Co. Ltd, Merck Sharp + Dohme Corp.. Active years: 1992-2017.


% Patents Active = 90.3

 

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 76(Granted Patents)


Location History:

  • Aberdeen, NJ (US) (1992 - 1995)
  • Rahway, NJ (US) (1998)
  • Holmdel, NJ (US) (1995 - 2017)

Company Filing History:


Years Active: 1992-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Reverse Transcriptase Inhibitors
Spirolactone Compounds
Indolocarbazole Glycosides
Michael Adducts
Conjugate Addition Reaction
Oxidation Process
Enantioselective Bioreduction
Chiral Additive
COX-2 Inhibitors
Stereoselective Alkylations
Phenyl Heterocycles
Cyclic Amino Alcohols
31 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David M. Tschaen

Introduction

David M. Tschaen, based in Holmdel, NJ, is a prolific inventor with a remarkable portfolio that includes 31 patents. His work predominantly focuses on developments in the field of pharmaceuticals, particularly in creating compounds that target HIV and other medical applications.

Latest Patents

Among his latest contributions to innovation are two significant patents. The first is titled "Process for making reverse transcriptase inhibitors." This invention introduces a novel method for synthesizing 3-(substituted phenoxy)-1-[(5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl])-pyridin-2(1H)-one derivatives. These compounds are crucial for inhibiting HIV reverse transcriptase and blocking HIV replication, aiding in the treatment of human immunodeficiency virus infection in humans.

The second patent is for "Process for making spirolactone compounds," which pertains to the production of spirolactone compounds analogous to a specific formula. These advancements contribute valuable resources to the pharmaceutical field, opening avenues for further research and therapeutic developments.

Career Highlights

David has had a distinguished career, significantly influenced by his tenure at prominent organizations, including Merck & Company, Inc. His role in such a leading company underscores his expertise and the impact of his innovations in the pharmaceutical sector.

Collaborations

Throughout his career, David has collaborated with remarkable individuals, including Richard D. Tillyer and Paul N. Devine. These partnerships have played a vital role in the advancement of his research and the success of his inventions.

Conclusion

David M. Tschaen's impressive portfolio of patents highlights his dedication to innovation and his substantial contributions to medical science. His work continues to inspire advances in healthcare, particularly in the fight against HIV, making him a noteworthy figure in the realm of inventions and patents.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…